European Commission approves RYBREVANT®▼ (amivantamab) in combination[...]
03/09/2024 | Press release | Distributed by Public on 03/09/2024 16:21
Please select the service you want to use:
Smartlinks | Aberdeen Funds | Company News | Shareholders | Shareholder Meeting | Proxy Statements | Investment Funds | Private Companies | Investment Companies
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact